SunHydrogen, Inc. operates in the renewable hydrogen production industry, developing photoelectrochemical (PEC) panels that produce hydrogen from sunlight and water without an externally applied electrical bias or a separate electrolyzer. Global hydrogen demand was approximately 100 million tonnes in 2024, with roughly half consumed in ammonia and methanol production and oil refining accounting for much of the remainder. Low emissions hydrogen production reached approximately one million tonnes in 2025 and is expected to account for slightly more than one percent of global production in 2026. The company targets decentralized hydrogen production under natural, unconcentrated sunlight, a segment that depends less on the infrastructure buildout that has slowed large centralized projects. The industry faces slower-than-anticipated adoption, with announced government targets for low emissions hydrogen production totaling almost 27 million tonnes per year by 2030, while projects with secured investment decisions suggest just over four million tonnes, and only China and the Netherlands are currently on track to meet their stated objectives.
The company's primary competitors in decentralized production include delivered hydrogen suppliers such as Linde, Air Liquide, and Air Products, as well as Plug Power, which operates both as a supplier of on-site production equipment and delivered hydrogen. In direct solar-to-hydrogen conversion, competitors include Solhyd, a Belgian company spun out of KU Leuven, and SoHHytec, a Swiss company spun out of EPFL. Centralized production competitors include Nel ASA, ITM Power, thyssenkrupp nucera, Siemens Energy, John Cockerill Hydrogen, Electric Hydrogen, Ohmium International, and Hysata. The company believes its approach is differentiated within the direct conversion field, but it has no commercial product, has generated no revenue from product sales, and has not produced hydrogen at commercial scale. Most competitors have substantially greater financial, technical, manufacturing, and personnel resources, and many have products in commercial operation and established customer relationships.
SunHydrogen is a development stage company that has not determined its commercial revenue model. It may sell hydrogen panels to customers, sell hydrogen produced by systems it owns or operates, license its technology to manufacturers, or pursue a combination of these approaches. The company's current preference is to sell panels, and its activities to identify potential hydrogen offtakers are intended in part to demonstrate demand for hydrogen produced using its technology. The company operates as a single reportable segment and has generated no revenue from product sales, with no customers for its products. It has funded operations primarily through sales of equity securities, principally under an equity purchase agreement with GHS Investments, LLC, which expired on June 3, 2026.
The company is pursuing two technology pathways. The thin film pathway uses commercially available, mass-produced thin film solar modules re-engineered with proprietary hydrogen module design, allowing manufacture on existing solar production lines without modification. Working with CTF Solar GmbH, the company has progressed to hydrogen modules with a nominal aperture area of 1.92 square meters, the standard size of a commercial solar module, and has built multiple hydrogen reactors incorporating those modules. The nanoparticle pathway uses patented Photoelectrosynthetically Active Heterostructures (PAH) technology, forming billions of electroplated nanoparticles per square centimeter, each acting as a self-contained water splitting unit. This pathway has demonstrated technical proof of concept, but efficiency, durability, manufacturing yield, scalability, and cost remain under development and validation.
During fiscal year 2026, the company continued development of its pilot hydrogen production system at the University of Texas at Austin's Center for Electromechanics, having built twelve hydrogen reactors for the site and installed six, with four commissioned and producing hydrogen under outdoor conditions. The company intends to have sixteen reactors operating at the facility by December 31, 2026, corresponding to approximately 30.7 square meters of nominal module aperture area. In February 2026, the company entered into a Technology and Manufacturing Services Agreement with CTF Solar GmbH, a subsidiary of China National Building Materials Group, with a near-term objective of producing up to 1,000 hydrogen modules of 1.92 square meters each. In April 2026, the company formed SunHydrogen Austria GmbH and SunHydrogen Japan GK, which had three and one employees, respectively, as of June 30, 2026. On August 11, 2026, the company entered into a Technology Collaboration and Intellectual Property Protection Agreement with Sparc Hydrogen Pty Ltd, a joint venture of Sparc Technologies Limited, Fortescue Ltd, and the University of Adelaide, under which its hydrogen modules will be evaluated at Sparc Hydrogen's facility in South Australia. The company also repurchased 1,486 shares of Series C Preferred Stock in September 2025 for an aggregate purchase price of $1,000,000.
For the fiscal year ended June 30, 2026, the company recognized revenue of $1,250 from consulting services provided to a related party, compared to $0 in the prior year. Operating expenses were $7,521,904, up from $5,816,192 in fiscal 2025. The company reported a net loss of $6,531,524 for fiscal 2026, compared to a net loss of $8,226,307 in fiscal 2025. Research and development expenditures were $4,344,574 for fiscal 2026 and $3,440,296 for fiscal 2025. As of June 30, 2026, the company had cash and cash equivalents of $12,130,904 and short-term investments of $19,929,164, with an accumulated deficit of $106,633,674.
The company's goal remains a production cost of $2.50 per kilogram of hydrogen, which management believes would allow renewable hydrogen to compete directly with hydrogen produced from natural gas. Techno-economic modeling prepared with Strategic Analysis, Inc. currently projects a production cost of approximately $4 to $5 per kilogram at commercial scale, before the benefit of any tax credits. The company expects the difference between that projection and its goal to be closed through improvements across several elements of its technology and supply chain, including solar-to-hydrogen conversion efficiency, operating lifetime, substitution of earth-abundant catalysts for precious metals, manufacturing yield and scale, and cost of substrates, semiconductor materials, coatings, housing, and balance of system components.
The company is pursuing two growth vectors. The first is the thin film pathway, which is designed to be manufactured on existing solar production lines without modification, allowing the company to draw on established manufacturing capacity rather than build its own. The Technology and Manufacturing Services Agreement with CTF Solar GmbH establishes a contracted manufacturing development program with a near-term objective of producing up to 1,000 hydrogen modules of 1.92 square meters each. The second growth vector is the nanoparticle pathway, which has demonstrated technical proof of concept and is intended to provide fault tolerance through billions of self-contained water splitting units per square centimeter. The company also formed SunHydrogen Austria GmbH to identify potential offtakers and apply for European funding, and SunHydrogen Japan GK to coordinate with partners in Japan and identify opportunities for pilot plants and potential offtakers.
The company's margin and cost outlook is centered on achieving its production cost goal of $2.50 per kilogram of hydrogen. The company expects to benefit from improvements in cost and efficiency achieved across the solar photovoltaic industry generally, because its devices incorporate materials and manufacturing processes also used in that industry. However, the company has not demonstrated any of these improvements at commercial scale, and several are outside its control. The projected production cost of approximately $4 to $5 per kilogram at commercial scale depends on assumptions regarding production volume, capital cost, insolation, and panel lifetime that may prove incorrect.
The company's operational outlook includes the continued development of its pilot system at the University of Texas at Austin, with a management target of sixteen reactors operating at the facility by December 31, 2026. The company leased additional space at 2500 Crosspark Road, Coralville, Iowa for module catalyst coating. The company's joint development agreement with Honda R&D Co., Ltd. expires on March 31, 2028, and its manufacturing services agreement with CTF Solar GmbH remains in effect. The company's sponsored research agreement with the University of Michigan expires on September 30, 2026, and the company is reviewing a possible extension. As of September 18, 2026, the company had 12 full-time employees and engaged several consultants.
The company's capital allocation priorities include research and development expenditures of $4,344,574 for fiscal 2026, up from $3,440,296 in fiscal 2025. The company does not currently have a committed source of additional capital and expects to raise funds primarily through sales of common stock or securities convertible into or exercisable for common stock. The company repurchased 1,486 shares of Series C Preferred Stock in September 2025 for an aggregate purchase price of $1,000,000 to reduce potential dilution. The company has never declared or paid cash dividends on its common stock and does not anticipate paying cash dividends in the foreseeable future.
The company faces several structural headwinds and constraints. The principal federal incentive for clean hydrogen production, the Section 45V Clean Hydrogen Production Tax Credit, may not be available for the company's technology because the emissions model prescribed by the regulations does not contemplate integrated photoelectrochemical water splitting. The company has not obtained a provisional emissions rate and cannot assure that it could do so within the time remaining before the construction deadline of January 1, 2028. In 2025, the U.S. Department of Energy reduced certain funding allocations for renewable hydrogen development, and government support for hydrogen has been subject to revision in the United States and elsewhere. The company's supply chain depends on materials that are geographically concentrated, including tellurium, which is among the least abundant elements in the earth's crust and is produced principally as a by-product of copper refining.
The company's cost projections do not assume the benefit of the Section 45V tax credit. The company expects production from unabated fossil fuels to remain less costly than renewable hydrogen in most regions in the near term, with government support policies remaining necessary. The company does not expect these conditions to change quickly. The company's ability to compete will depend on achieving conversion efficiency, operating lifetime, and manufacturing cost that it has not yet demonstrated, and on persuading customers to produce hydrogen on site rather than purchase it delivered.
Management's message emphasizes the company's progress in developing its pilot system and advancing its technology pathways, while acknowledging the significant challenges remaining. The company's goal remains a production cost of $2.50 per kilogram of hydrogen, with current techno-economic modeling projecting approximately $4 to $5 per kilogram at commercial scale. Management highlights the formation of SunHydrogen Austria GmbH and SunHydrogen Japan GK to expand the company's international presence and identify potential offtakers. The company's strategic priorities include completing its pilot program at the University of Texas at Austin, advancing its manufacturing development program with CTF Solar GmbH, and continuing to develop both its thin film and nanoparticle technology pathways. Management also emphasizes the need to raise additional capital, as the equity purchase agreement with GHS Investments, LLC expired on June 3, 2026, and the company does not currently have a committed source of additional capital.
For the fiscal year ended June 30, 2026, the company reported revenue of $1,250, compared to $0 in the prior year. Net loss was $6,531,524 for fiscal 2026, compared to a net loss of $8,226,307 in fiscal 2025. Basic and diluted earnings per share were $0.00 for both years. Operating expenses were $7,521,904 in fiscal 2026, up from $5,816,192 in fiscal 2025. Other income and expenses were $989,130 in fiscal 2026, compared to $(2,410,115) in fiscal 2025, with the improvement primarily due to a decrease in unrealized loss on the change in fair value of investments, related party of $4,101,402. The company reported a working capital surplus of $31,819,205 as of June 30, 2026, compared to $37,048,679 as of June 30, 2025. Cash used in operating activities was $5,065,357 for fiscal 2026, compared to $3,647,278 in fiscal 2025. Cash used in investing activities was $17,200,794, compared to $2,924,988 in the prior year. Cash used in financing activities was $231,047, compared to cash provided of $2,156,096 in the prior year. The company had cash and cash equivalents of $12,130,904 as of June 30, 2026, down from $34,628,625 as of June 30, 2025. Short-term investments were $19,929,164 as of June 30, 2026, up from $2,997,460 as of June 30, 2025. The company had an accumulated deficit of $106,610,074 as of June 30, 2026, and total shareholders' equity of $31,764,904. The company recognized a deemed dividend on repurchase of preferred stock of $851,400 in fiscal 2026, which reduced net income available to common stockholders to $5,680,124. The company also recorded a foreign currency translation adjustment of $(11,992) in fiscal 2026. The company's investment in TECO Fuel Cell Technology, a related party, had no unrealized loss in fiscal 2026, compared to a loss of $4,101,402 in fiscal 2025.
The company has generated no revenue from product sales, has no commercial product, and has not produced hydrogen at commercial scale, and it may never become profitable. As of June 30, 2026, the company had an accumulated deficit of $106,633,674 and incurred a net loss of $6,555,124 for the fiscal year then ended. The equity purchase agreement with GHS Investments, LLC, which had been the principal source of funding, expired on June 3, 2026, and the company does not currently have a committed source of additional capital. The company's goal of producing hydrogen at a cost of $2.50 per kilogram is challenged by current techno-economic modeling projecting a production cost of approximately $4 to $5 per kilogram at commercial scale, and the improvements required to close that gap depend substantially on factors outside the company's control. The Section 45V Clean Hydrogen Production Tax Credit, which provides a credit of up to $3.00 per kilogram of qualified clean hydrogen, may not be available for the company's technology because the emissions model does not contemplate integrated photoelectrochemical water splitting, and the company has not obtained a provisional emissions rate. The company's supply chain depends on tellurium, which is among the least abundant elements in the earth's crust and is produced principally as a by-product of copper refining, and the company does not have long-term supply agreements that guarantee volumes, pricing, or availability for modules, catalysts, or precious metals. The company's joint development agreement with Honda R&D Co., Ltd. expires on March 31, 2028, and its sponsored research agreement with the University of Michigan expires on September 30, 2026, with no assurance of extension. The company's insurance coverage is limited, consisting only of workers' compensation and property coverage required under its facility lease, and it does not maintain commercial general liability, theft, or casualty insurance covering its equipment or operations.
Analysis on 9/25/2026
